Allegiance Financial Group Advisory Services’s Journey Medical DERM Stock Holding History

Allegiance Financial Group Advisory Services’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$71.2K	–	185
2025 Q3	$71.2K	Hold	10,000	–	–	0.02%	163
2025 Q2	$71.8K	Hold	10,000	–	–	0.02%	151
2025 Q1	$59K	Hold	10,000	–	–	0.02%	138
2024 Q4	$39.1K	Hold	10,000	–	–	0.01%	112
2024 Q3	$56.5K	Hold	10,000	–	–	0.02%	79
2024 Q2	$56.4K	Hold	10,000	–	–	0.02%	72
2024 Q1	$36.8K	Hold	10,000	–	–	0.02%	71
2023 Q4	$57.6K	Hold	10,000	–	–	0.03%	65
2023 Q3	$27.4K	Hold	10,000	–	–	0.02%	64
2023 Q2	$15.9K	Hold	10,000	–	–	0.01%	67
2023 Q1	$15.7K	Hold	10,000	–	–	0.01%	66
2022 Q4	$19.2K	Buy	+10,000	New	+$19.8K	0.02%	67

Other funds holding DERM

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Allegiance Financial Group Advisory Services's DERM Position: Q4 2025 in Review

Allegiance Financial Group Advisory Services sold out of Journey Medical (DERM) in Q4 2025, closing a stake of 10,000 shares — an estimated $71.2K sold.

Allegiance Financial Group Advisory Services first reported a position in DERM in Q4 2022 and held it in 12 quarters. The position peaked at $71.8K in Q2 2025. 77 funds tracked by Wall St. Rank hold DERM as of Q4 2025.

Allegiance Financial Group Advisory Services reported no remaining Journey Medical position as of Q4 2025 after selling out during the quarter.
Allegiance Financial Group Advisory Services sold 10,000 Journey Medical shares in Q4 2025, an estimated $71.2K.
Allegiance Financial Group Advisory Services first reported a position in Journey Medical in Q4 2022 and held it in 12 quarters.
Allegiance Financial Group Advisory Services's Journey Medical position peaked at $71.8K in Q2 2025.
77 funds tracked by Wall St. Rank held Journey Medical as of Q4 2025.

Based on Allegiance Financial Group Advisory Services's 13F filing for Q4 2025, filed 3 Feb 2026.